“Practice Update” recently highlighted the results of a clinical trial involving stereotactic ablative body radiotherapy (SABR), a noninvasive approach for the treatment of oligometastases. The... Read More
As of 2014, MBCN made a commitment that all memorial contributions received would go to funding metastatic research, Although metastatic breast cancer is responsible for virtually every breast cancer death, it receives only a tiny percentage of the billions dedicated to breast cancer research. MBCN is a founding member of The Metastatic Breast Cancer Alliance. The Alliance’s Metastatic Breast Cancer Landscape Analysis released in October 2014 found that metastatic focused research made up only 7% of the $15 billion invested in breast cancer research from 2006 to 2013 by the major governmental and nonprofit funders from North America and the United Kingdom. Breast cancer remains the second leading cause of cancer death for women in the US, and it is the leading cause of cancer death for women globally. We know research holds the key to changing those statistics.